Global Phosphoproteomic Analysis of Insulin/Akt/mTORC1/S6K Signaling in Rat Hepatocytes

被引:24
|
作者
Zhang, Yuanyuan [1 ]
Zhang, Yajie [2 ]
Yu, Yonghao [2 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA
基金
美国国家卫生研究院;
关键词
proteomics; phosphoproteomics; quantification; kinase; signaling; insulin; mTOR; diabetes; liver; insulin resistance; PROTEIN-PHOSPHORYLATION; FEEDBACK INHIBITION; INSULIN-RESISTANCE; PROTEOMIC ANALYSIS; AKT SUBSTRATE; X-RECEPTOR; STIMULATION; REVEALS; LIVER; MTOR;
D O I
10.1021/acs.jproteome.7b00140
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Insulin resistance is a hallmark of type 2 diabetes. Although multiple genetic and physiological factors interact to cause insulin resistance, deregulated signaling by phosphorylation is a common underlying mechanism. In particular, the specific phosphorylation-dependent regulatory mechanisms and signaling outputs of insulin are poorly understood in hepatocytes, which represents one of the most important insulin-responsive cell types. Using primary rat hepatocytes as a model system, we performed reductive dimethylation (ReDi)-based quantitative mass spectrometric analysis and characterized the phosphoproteome that is regulated by insulin as well as its key downstream kinases including Akt, mTORC1, and S6K. We identified a total of 12 294 unique, confidently localized phosphorylation sites and 3805 phosphorylated proteins in this single cell type. Detailed bioinformatic analysis on each individual data set identified both known and previously unrecognized targets of this key insulin downstream effector pathway. Furthermore, integrated analysis of the hepatic Akt/mTORC1/S6K signaling axis allowed the delineation of the substrate specificity of several close-related kinases within the insulin signaling pathway. We expect that the data sets will serve as an invaluable resource, providing the foundation for future hypothesis-driven research that helps delineate the molecular mechanisms that underlie the pathogenesis of type 2 diabetes and related metabolic syndrome.
引用
收藏
页码:2825 / 2835
页数:11
相关论文
共 50 条
  • [31] The growing importance of mTORC1-S6K1 signaling in kidney
    Siroky, Brian J.
    Bitzer, Markus
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2009, 297 (03) : F583 - F584
  • [32] IKKβ Activation of S6K Is Responsible for IRS-1 Phosphorylation and Insulin Resistant in the TNF-Signaling Pathway
    Zhang, Jin
    Gao, Zhanguo
    Yin, Jun
    Quon, Michael J.
    Ye, Jianping
    DIABETES, 2009, 58 : A346 - A346
  • [33] Oleanolic acid suppresses the proliferation of human bladder cancer by Akt/mTOR/S6K and ERK1/2 signaling
    Mu, Da-Wei
    Guo, He-Qing
    Zhou, Gao-Biao
    Li, Jian-Ye
    Su, Bin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 13864 - 13870
  • [34] Amino Acids Attenuate Insulin Action on Gluconeogenesis and Promote Fatty Acid Biosynthesis via mTORC1 Signaling Pathway in trout Hepatocytes
    Dai, Weiwei
    Panserat, Stephane
    Plagnes-Juan, Elisabeth
    Seiliez, Iban
    Skiba-Cassy, Sandrine
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 36 (03) : 1084 - 1100
  • [35] The involvement of Akt, mTOR, and S6K in the in vivo effect of IGF-1 on the regulation of rat cardiac Na+/K+-ATPase
    Banjac, Katarina
    Obradovic, Milan
    Zafirovic, Sonja
    Essack, Magbubah
    Gluvic, Zoran
    Sunderic, Milos
    Nedic, Olgica
    Isenovic, Esma R.
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [36] LRP6 Bidirectionally Regulates Insulin Sensitivity through Insulin Receptor and S6K Signaling in Rats with CG-IUGR
    Xue-mei Xie
    Qiu-li Cao
    Yu-jie Sun
    Jie Zhang
    Kai-li Liu
    Ying-fen Qin
    Wen-jun Long
    Zuo-jie Luo
    Xiao-wei Li
    Xing-huan Liang
    Guan-dou Yuan
    Xiao-ping Luo
    Xiu-ping Xuan
    Current Medical Science, 2023, 43 : 274 - 283
  • [37] LRP6 Bidirectionally Regulates Insulin Sensitivity through Insulin Receptor and S6K Signaling in Rats with CG-IUGR
    Xie, Xue-mei
    Cao, Qiu-li
    Sun, Yu-jie
    Zhang, Jie
    Liu, Kai-li
    Qin, Ying-fen
    Long, Wen-jun
    Luo, Zuo-jie
    Li, Xiao-wei
    Liang, Xing-huan
    Yuan, Guan-dou
    Luo, Xiao-ping
    Xuan, Xiu-ping
    CURRENT MEDICAL SCIENCE, 2023, 43 (02) : 274 - 283
  • [38] Fuzhenghefuzhiyang Formula (FZHFZY) Improves Epidermal Differentiation via Suppression of the Akt/mTORC1/S6K1 Signalling Pathway in Psoriatic Models
    Lu, Yue
    Chen, Haiming
    Zhang, Junhong
    Tang, Bin
    Zhang, Hongyu
    Ma, Changju
    Tang, Xiaojuan
    Li, Li
    Wu, Jingjing
    Wei, Jianan
    Li, Shaoping
    Yang, Lei
    Han, Ling
    Lu, Chuanjian
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [39] Direct imaging of the recruitment and phosphorylation of S6K1 in the mTORC1 pathway in living cells
    Ahmed, Abdullah R.
    Owens, Raymond J.
    Stubbs, Christopher D.
    Parker, Anthony W.
    Hitchman, Richard
    Yadav, Rahul B.
    Dumoux, Maud
    Hawes, Chris
    Botchway, Stanley W.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [40] S6K1 Alternative Splicing Modulates Its Oncogenic Activity and Regulates mTORC1
    Ben-Hur, Vered
    Denichenko, Polina
    Siegfried, Zahava
    Maimon, Avi
    Krainer, Adrian
    Davidson, Ben
    Karni, Rotem
    CELL REPORTS, 2013, 3 (01): : 103 - 115